$0.9839
0.01391.43%
Ultimo aggiornamento: Nov 18, 12:36 PM
Tieni traccia delle ultime attività di insider trading TScan Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni TScan Therapeutics.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
May 21, 2025 | 10% OWNER | 2.59M | $1.20 | $3.11M | BUY | 48.32% | 7.95M | May 19 - May 20 | ||
Dec 16, 2024 | 10% OWNER | 131.80K | $2.93 | $385.77K | BUY | 2.52% | 5.36M | Dec 12 - Dec 13 | ||
Nov 19, 2024 | 10% OWNER | 947.00 | $4.34 | $4.11K | BUY | 0.02% | 5.23M | Nov 15 | ||
Sep 24, 2024 | — | 5.00K | $5.29 | $26.45K | BUY | 7.69% | 70.00K | Sep 23 | ||
Aug 27, 2024 | — | 10.00K | $5.61 | $56.10K | BUY | 18.18% | 65.00K | Aug 23 - Aug 26 | ||
Aug 27, 2024 | SEE REMARKS | -7.50K | $4.58 | -$420.60K | SELL | -61.39% | 4.72K | Aug 23 | ||
Dec 21, 2023 | — | 29.15K | $4.89 | $142.46K | BUY | 40.97% | 100.29K | Dec 18 - Dec 19 | ||
Dec 18, 2023 | — | 5.00K | $5.08 | $25.40K | BUY | 10.00% | 55.00K | Dec 14 | ||
Jun 06, 2023 | DIRECTOR | 37.88K | $2.63 | $99.56K | BUY | 113.89% | 71.14K | Jun 02 | ||
Jun 02, 2023 | 10% OWNER | -25.40K | $2.52 | -$63.95K | SELL | -0.48% | 5.22M | May 31 | ||
Dec 29, 2022 | CHIEF FINANCIAL OFFICER | 6.00K | $1.54 | $9.22K | BUY | 22.32% | 32.88K | Dec 27 - Dec 28 | ||
May 20, 2022 | CHIEF EXECUTIVE OFFICER | 25.00K | $3.59 | $89.82K | BUY | 17.06% | 171.57K | May 18 | ||
May 12, 2022 | DIRECTOR | 1.36M | $1.88 | $2.56M | BUY | 116.34% | 2.53M | May 10 - May 11 | ||
Mar 28, 2022 | CHIEF FINANCIAL OFFICER | 15.00K | $3.40 | $50.98K | BUY | 126.21% | 26.89K | Mar 24 | ||
Sep 27, 2021 | CHIEF LEGAL OFFICER | 4.72K | $7.48 | $35.26K | BUY | ∞ | 4.72K | Sep 23 | ||
Sep 22, 2021 | CHIEF FINANCIAL OFFICER | 5.00K | $6.32 | $31.59K | BUY | 72.62% | 11.88K | Sep 21 | ||
Sep 22, 2021 | CHIEF SCIENTIFIC OFFICER | 5.00K | $6.22 | $31.10K | BUY | 11.17% | 49.77K | Sep 20 - Sep 21 | ||
Sep 13, 2021 | CHIEF FINANCIAL OFFICER | 5.88K | $8.48 | $49.93K | BUY | 588.50% | 6.88K | Sep 09 | ||
Sep 09, 2021 | CHIEF EXECUTIVE OFFICER | 11.00K | $8.73 | $96.07K | BUY | 12.66% | 97.90K | Sep 08 | ||
Aug 31, 2021 | CHIEF BUSINESS OFFICER | 2.50K | $9.08 | $22.71K | BUY | ∞ | 2.50K | Aug 27 | ||
Jul 22, 2021 | 10% OWNER | 1.28M | $15.00 | $2.00M | BUY | 1048.65% | 1.40M | Jul 20 | ||
Jul 22, 2021 | DIRECTOR | 1.43M | $15.00 | $21.38M | BUY | ∞ | 1.32M | Jul 20 | ||
Jul 22, 2021 | CHIEF FINANCIAL OFFICER | 1.00K | $15.00 | $15.00K | BUY | ∞ | 1.00K | Jul 20 |
Sfoglia insider trading su tutte le azioni.